Ian Ratheal, MD
Orthopaedic Surgery · New Braunfels, TXNPI 1639558810
Payments from drug & device makers
Across 70 payments — averaging $105.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$3K
- Stryker$2K
- Orthalign Inc$879
- Bioventus LLC$260
- Johnson & Johnson$239
- Davol Inc.$142
- plus $525 from 8 others
What the payments were for
- Speaking & faculty fees$1,50020%
- Travel & lodging$2,18830%
- Food & beverage$3,68850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 24 | $3,267 |
| Stryker | 13 | $2,065 |
| Orthalign Inc | 9 | $879 |
| Bioventus LLC | 8 | $260 |
| Johnson & Johnson | 5 | $239 |
| Davol Inc. | 1 | $142 |
| Regeneron Healthcare Solutions, Inc. | 1 | $131 |
| Ortho Development Corporation | 1 | $107 |
| SPR Therapeutics, Inc | 1 | $78 |
| Corium, LLC | 1 | $71 |
| Pacira Pharmaceuticals Incorporated | 2 | $55 |
| Medical Device Business Services, Inc. | 2 | $44 |
| Abbott | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$4,409
- AXSOS$1,279
- GAMMA$1,279
- VARIAX$1,279
- T2$1,279
- HOFFMANN$1,279
- ORTHALIGN PLUS$721
- MAKO$301
- TRITANIUM$175
- TRIATHLON$175
- CFN CHLORAPREP$142
- DJO Surgical Cobalt HV Bone Cement$114
- DJO Surgical CLP Hip System$114
- DJO Surgical 3DKnee System$114
- TRAUMA$114
- Entrada Hip Stem$107
- ADAPT$100
How this compares
$7,376 in reported general payments places this provider in the 55th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $3,542 |
| Gabapentin | 40 | $278 |
| Oxycodone Hcl | 22 | $250 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $209 |
| Celecoxib | 11 | $151 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $99 |
| Meloxicam | 60 | $93 |
| Tramadol Hcl | 25 | $90 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New Braunfels
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- J Richard EvansonPlano$8.1M
- Stefan KreuzerHouston$7M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Howard HarrisBedford$4.6M
- Tiffany HuynhHouston$4.6M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.